Reinhardt Max's Form 4 filing
Pacira BioSciences, Inc. (PCRX) · filed Jun 8, 2022
- Accession no.
- 0001209191-22-035229
- Filed
- Jun 8, 2022
- Trade date
- Jun 6-8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $323.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reinhardt MaxCIK 0001780058 | Officer (President, Rest of World) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2022 | Common Stock | SSaleDisposed | −2,817 | $61.37 | −$172,879.29 | 26,833 | Direct | |
| Jun 7, 2022 | Common Stock | SSaleDisposed | −2,433 | $62.00 | −$150,846 | 24,400 | Direct | |
| Jun 8, 2022 | Common Stock | AGrant or awardAcquired | +7,950 | $0.00 | $0 | 32,250 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2022 | Common Stock | AGrant or awardAcquired | +19,900 | $0.00 | $0 | 19,900 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.